臨床試驗

CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Proximal Popliteal Artery

NCT：NCT05734157 · COMPLETED

NCT IDNCT05734157

狀態COMPLETED

開始日期2022-02-17

完成時間2025-08-27

SponsorAbbott Medical Devices (INDUSTRY)

First posted2023-02-17

Last updated2026-05-13

簡要摘要

The CVT-SFA Trial investigates the inhibition of restenosis using the CVT Everolimus-coated PTA Catheter in the treatment of de-novo occluded/ stenotic or re-occluded/restenotic superficial femoral or popliteal arteries.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。